The distinction is made as women with NCCAH manifest greater concentrations of 17-hydroxyprogesterone and progesterone than women with PCOS, who present insulin resistance, obesity, polycystic ovary morphology, and increased LH/FSH ratios (28). The gene discussed is BRD2; the disease is polycystic ovary syndrome.